Penn State Health offers leading-edge research and expertise in the diagnosis and management of
conditions involving the urinary tract through its relationship with Penn State College of Medicine.
Learn about our latest clinical trials for bladder cancer:
• Chemoablative Gel – Offering a nonsurgical option for destroying bladder tumors in patients with
low-grade, non-muscle-invasive bladder cancer.
• New Hematuria Urine Test – Could replace the full work-up for some lower-risk patients with blood
in the urine.
• Vascular Targeted Photodynamic Therapy – Endoscopic, kidney-preserving cancer treatment for
low-grade upper tract carcinoma.
• Noninvasive Urine Test – Detects upper tract carcinoma recurrence in low-grade patients currently
under surveillance.
Now enrolling patients and accepting referrals. Call 717-531-5930 or email UrologyResearch@
pennstatehealth.psu.edu. Visit studyfinder.psu.edu for more clinical trials at Penn State Health.
Nationally Recognized Expertise and
Discovery for Urologic Cancers
pennstatehealth.org/urology
SRG_21750_HMC_OWN_PRT_INT_1022
